Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swiss Polychemical Industries is an established Indian pharmaceutical company that specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates. Founded in 1988 and headquartered in Mumbai, the company operates modern manufacturing facilities that comply with international quality standards, including Good Manufacturing Practice (GMP). Their extensive product portfolio focuses on therapeutic areas such as cardiovascular health, endocrinology, and the central nervous system. SPI serves a global clientele, providing both off-the-shelf API products and custom synthesis services for specialized chemical requirements. The company is recognized for its expertise in complex chemical reactions and its commitment to delivering high-purity components for the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swiss Polychemical Industries.